Literature DB >> 19374496

Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article.

Robert M Starke1, Ricardo J Komotar, Zachary L Hickman, Yehuda E Paz, Angela G Pugliese, Marc L Otten, Matthew C Garrett, Mitchell S V Elkind, Randolph S Marshall, Joanne R Festa, Philip M Meyers, E Sander Connolly.   

Abstract

OBJECT: The object of this study was to report the clinical features, surgical treatment, and long-term outcomes in adults with moyamoya phenomenon treated at a single institution in the US.
METHODS: Forty-three adult patients with moyamoya disease (mean age 40 +/- 11 years [SD], range 18-69 years) were treated with encephaloduroarteriosynangiosis (EDAS). Neurologists examined patients pre- and postoperatively. Follow-up was obtained in person or by structured telephone interview (median 41 months, range 4-126 months). The following outcomes were collected: transient ischemic attack (TIA), infarction, graft collateralization, change in cerebral perfusion, and functional level according to the modified Rankin scale (mRS). Kaplan-Meier estimates of infarction risk were calculated for comparison of surgically treated and contralateral hemispheres.
RESULTS: The majority of patients were women (65%), were Caucasian (65%), presented with ischemic symptoms (98%), and had bilateral disease (86%). Nineteen patients underwent unilateral and 24 patients bilateral EDAS (67 treated hemispheres). Collateral vessels developed in 50 (98%) of 52 hemispheres for which imaging was available and there was evidence of increased perfusion on SPECT scans in 41 (82%) of the 50 hemispheres evaluated. Periprocedural infarction (< 48 hours) occurred in 3% of the hemispheres treated. In the follow-up period patients experienced 10 TIAs, 6 infarctions, and 1 intracranial hemorrhage. Although the hemisphere selected for surgery was based upon patients' symptoms and severity of pathology, the 5-year infarction-free survival rate was 94% in the surgically treated hemispheres versus < 36% in the untreated hemispheres (p = 0.007). After controlling for age and sex, infarction was 89% less likely to occur in the surgically treated hemispheres than in the contralateral hemispheres (hazard ratio 0.11, 95% CI 0.02-0.56). Thirty-eight (88%) of 43 patients had preserved or improved mRS scores, relative to baseline status.
CONCLUSIONS: In this mixed-race population of North American patients, indirect bypass promoted adequate pial collateral development and increased perfusion in the majority of adult patients with moyamoya disease. Patients had low rates of postoperative TIAs, infarction, and hemorrhage, and the majority of patients had preserved or improved functional status.

Entities:  

Mesh:

Year:  2009        PMID: 19374496      PMCID: PMC2783413          DOI: 10.3171/2009.3.JNS08837

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  30 in total

1.  Thomas Willis Lecture. Acute clinical trials: An expression of concern.

Authors:  J P Mohr
Journal:  Cerebrovasc Dis       Date:  1999       Impact factor: 2.762

2.  Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article.

Authors:  Robert M Starke; Ricardo J Komotar; Zachary L Hickman; Yehuda E Paz; Angela G Pugliese; Marc L Otten; Matthew C Garrett; Mitchell S V Elkind; Randolph S Marshall; Joanne R Festa; Philip M Meyers; E Sander Connolly
Journal:  J Neurosurg       Date:  2009-11       Impact factor: 5.115

3.  Effects of encephalo-duro-arterio-synangiosis on childhood moyamoya patients--swift disappearance of ischemic attacks and maintenance of mental capacity.

Authors:  Y Matsushima; M Aoyagi; Y Koumo; Y Takasato; T Yamaguchi; H Masaoka; R Suzuki; K Ohno
Journal:  Neurol Med Chir (Tokyo)       Date:  1991-11       Impact factor: 1.742

4.  Long-term results of surgically treated moyamoya disease.

Authors:  H Nakashima; T Meguro; S Kawada; N Hirotsune; T Ohmoto
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

5.  A clinical comparison of definite moyamoya disease between South Korea and Japan.

Authors:  K Ikezaki; D H Han; T Kawano; N Kinukawa; M Fukui
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

Review 6.  Moyamoya disease: the disorder and surgical treatment.

Authors:  K Ueki; F B Meyer; J F Mellinger
Journal:  Mayo Clin Proc       Date:  1994-08       Impact factor: 7.616

7.  [Hemorrhagic type of moyamoya disease].

Authors:  N Saeki; A Yamaura; S Hoshi; K Sunami; N Ishige; Y Hosoi
Journal:  No Shinkei Geka       Date:  1991-08

8.  [Effects of indirect EC/IC bypass operations on adult moyamoya patients].

Authors:  Y Matsushima; R Suzuki; T Yamaguchi; H Tabata; Y Inaba
Journal:  No Shinkei Geka       Date:  1986-12

9.  Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey.

Authors:  Shinichi Kuriyama; Yasuko Kusaka; Miki Fujimura; Kenji Wakai; Akiko Tamakoshi; Shuji Hashimoto; Ichiro Tsuji; Yutaka Inaba; Takashi Yoshimoto
Journal:  Stroke       Date:  2007-11-29       Impact factor: 7.914

10.  The role of indirect extracranial-intracranial bypass in the treatment of symptomatic intracranial atheroocclusive disease.

Authors:  Ricardo J Komotar; Robert M Starke; Marc L Otten; Maxwell B Merkow; Matthew C Garrett; Randolph S Marshall; Mitchell S V Elkind; E Sander Connolly
Journal:  J Neurosurg       Date:  2009-05       Impact factor: 5.115

View more
  16 in total

1.  Clinical features and outcome in North American adults with idiopathic basal arterial occlusive disease without moyamoya collaterals.

Authors:  Manu S Goyal; Christopher L Hallemeier; Gregory J Zipfel; Keith M Rich; Robert L Grubb; Michael R Chicoine; Christopher J Moran; DeWitte T Cross; Ralph G Dacey; Colin P Derdeyn
Journal:  Neurosurgery       Date:  2010-08       Impact factor: 4.654

2.  Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article.

Authors:  Robert M Starke; Ricardo J Komotar; Zachary L Hickman; Yehuda E Paz; Angela G Pugliese; Marc L Otten; Matthew C Garrett; Mitchell S V Elkind; Randolph S Marshall; Joanne R Festa; Philip M Meyers; E Sander Connolly
Journal:  J Neurosurg       Date:  2009-11       Impact factor: 5.115

3.  Clinical and angiographic features and stroke types in adult moyamoya disease.

Authors:  D-K Jang; K-S Lee; H K Rha; P-W Huh; J-H Yang; I S Park; J-G Ahn; J H Sung; Y-M Han
Journal:  AJNR Am J Neuroradiol       Date:  2014-01-02       Impact factor: 3.825

4.  Contralateral cerebral hemodynamic changes after unilateral direct revascularization in patients with moyamoya disease.

Authors:  Yan Ma; Meng Li; Li Q Jiao; Hong Q Zhang; Feng Ling
Journal:  Neurosurg Rev       Date:  2011-05-03       Impact factor: 3.042

5.  Transcranial Doppler ultrasound CO2 challenge complicated by subarachnoid hemorrhage in patient with moyamoya syndrome.

Authors:  Megan M Donohue; Anne Moore; Dean Shibata; Stephanie Ebel-Caswell; Kyra J Becker
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

6.  Encephaloduroarteriosynangiosis (EDAS) treatment of moyamoya syndrome: evaluation by computed tomography perfusion imaging.

Authors:  Xiang Guo; Xuexia Yuan; Lingyun Gao; Yueqin Chen; Hao Yu; Weijian Chen; Yunjun Yang; Zhen Chong; Zhanguo Sun; Feng Jin; Deguo Liu
Journal:  Eur Radiol       Date:  2021-05-06       Impact factor: 5.315

7.  Hemorrhage and risk of further hemorrhagic strokes following cerebral revascularization in Moyamoya disease: A review of the literature.

Authors:  Robert W J Ryan; Abhineet Chowdhary; Gavin W Britz
Journal:  Surg Neurol Int       Date:  2012-06-29

8.  Moyamoya syndrome in a known case of pulmonary tuberculosis.

Authors:  Fahmi Yousef Khan; Hussain Kamal; Rania Musa; Ahmed Hayati
Journal:  J Neurosci Rural Pract       Date:  2010-07

9.  A Prospective, Longitudinal Magnetic Resonance Imaging Evaluation of Cerebrovascular Reactivity and Infarct Development in Patients With Intracranial Stenosis.

Authors:  Meher R Juttukonda; Larry T Davis; Sarah K Lants; Spencer L Waddle; Chelsea A Lee; Niral J Patel; Lori C Jordan; Manus J Donahue
Journal:  J Magn Reson Imaging       Date:  2021-03-24       Impact factor: 5.119

10.  Neurocognitive dysfunction in adult moyamoya disease.

Authors:  Joanne R Festa; Lauren R Schwarz; Neil Pliskin; C Munro Cullum; Laura Lacritz; Fady T Charbel; Dana Mathews; Robert M Starke; E Sander Connolly; Randolph S Marshall; Ronald M Lazar
Journal:  J Neurol       Date:  2009-12-24       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.